1. An Intronic Risk SNP rs12454712 for Central Obesity Acts As an Allele-Specific Enhancer To Regulate BCL2 Expression
- Author
-
Yu Rong, Tie-Lin Yang, Xiao-Rong Zhou, Mengqi Zeng, Shan-Shan Dong, Feng Jiang, Xiao-Mei Tuo, Yan Guo, Dong-Li Zhu, Zhihui Feng, and Jia-Bin Chen
- Subjects
Genetics ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,Intronic SNP ,SNP ,CRISPR ,Genome-wide association study ,Single-nucleotide polymorphism ,Biology ,Enhancer ,Transcription factor ,Epigenomics - Abstract
Genome-wide association studies (GWAS) have reproducibly associated the single nucleotide polymorphism (SNP) rs12454712 with waist-to-hip ratio adjusted for BMI (WHRadjBMI), but the functional role underlying this intronic variant is unknown. Integrative genomic and epigenomic analyses supported rs12454712 as a functional independent variant. We further demonstrated that rs12454712 acted as an allele-specific enhancer regulating expression of its located gene BCL2 by using dual-luciferase reporter assays and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9. Specifically, the rs12454712-C allele can bind transcription factor ZNF329, which efficiently elevates the enhancer activity and increases BCL2 expression. Knocking down Bcl2 in 3T3-L1 cells led to the downregulation of adipogenic differentiation marker genes and increased cell apoptosis. A significant negative correlation between BCL2 expression in subcutaneous adipose tissues and obesity was observed. Our findings illustrate the molecular mechanisms behind the intronic SNP rs12454712 for central obesity, which would be a potential and promising target for developing appropriate therapies.
- Published
- 2021
- Full Text
- View/download PDF